Evidence map›Paper›PMID 27241794›Full record

ReviewWiley interdisciplinary reviews. Nanomedicine and nanobiotechnology2017

Detection and treatment of atherosclerosis using nanoparticles.

Jia Zhang, Yujiao Zu, Chathurika S Dhanasekara, Jun Li, Dayong Wu, Zhaoyang Fan, Shu Wang

Open access · greenAbstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 132 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Vascular medicine in the 21World journal of clinical cases · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jia ZhangDepartment of Nutritional Sciences, Texas Tech University, Lubbock, TX, USA.
Yujiao ZuDepartment of Nutritional Sciences, Texas Tech University, Lubbock, TX, USA.
Chathurika S DhanasekaraDepartment of Nutritional Sciences, Texas Tech University, Lubbock, TX, USA.
Jun LiLaboratory Animal Center, Peking University, Beijing, PR China.
Dayong WuNutritional Immunology Laboratory, Jean Mayer Human Nutrition Research Center on Aging, Tufts University, Boston, MA, USA.
Zhaoyang FanDepartment of Electrical and Computer Engineering and Nano Tech Center, Texas Tech University, Lubbock, TX, USA.
Shu WangDepartment of Nutritional Sciences, Texas Tech University, Lubbock, TX, USA.
Texas Tech University · USJean Mayer Human Nutrition Research Center on Aging · USPeking University · CN

Funding

Anti-obesity effects of adipose-targeting resveratrol nanocarriersR15AT008733 · NCCIH · TEXAS TECH UNIVERSITY · PI WANG, SHU · 2015 to 2015
$395k
Green Tea Nanocarriers: A Promising Approach for the Prevention and Treatment ofR15AT007013 · NCCIH · TEXAS TECH UNIVERSITY · PI WANG, SHU · 2011 to 2011
$314k
NCCIH NIH HHS R15 AT007013NCCIH NIH HHS R15 AT008733
6 · The paper itself

Abstract

Atherosclerosis is the key pathogenesis of cardiovascular disease, which is a silent killer and a leading cause of death in the United States. Atherosclerosis starts with the adhesion of inflammatory monocytes on the activated endothelial cells in response to inflammatory stimuli. These monocytes can further migrate into the intimal layer of the blood vessel where they differentiate into macrophages, which take up oxidized low-density lipoproteins and release inflammatory factors to amplify the local inflammatory response. After accumulation of cholesterol, the lipid-laden macrophages are transformed into foam cells, the hallmark of the early stage of atherosclerosis. Foam cells can die from apoptosis or necrosis, and the intracellular lipid is deposed in the artery wall forming lesions. The angiogenesis for nurturing cells is enhanced during lesion development. Proteases released from macrophages, foam cells, and other cells degrade the fibrous cap of the lesion, resulting in rupture of the lesion and subsequent thrombus formation. Thrombi can block blood circulation, which represents a major cause of acute heart events and stroke. There are generally no symptoms in the early stages of atherosclerosis. Current detection techniques cannot easily, safely, and effectively detect the lesions in the early stages, nor can they characterize the lesion features such as the vulnerability. While the available therapeutic modalities cannot target specific molecules, cells, and processes in the lesions, nanoparticles appear to have a promising potential in improving atherosclerosis detection and treatment via targeting the intimal macrophages, foam cells, endothelial cells, angiogenesis, proteolysis, apoptosis, and thrombosis. Indeed, many nanoparticles have been developed in improving blood lipid profile and decreasing inflammatory response for enhancing therapeutic efficacy of drugs and decreasing their side effects. WIREs Nanomed Nanobiotechnol 2017, 9:e1412. doi: 10.1002/wnan.1412 For further resources related to this article, please visit the WIREs website.

Indexed as

AtherosclerosisNanoparticlesTheranostic NanomedicineAnimalsDisease Models, AnimalEndothelial CellsHumansMiceMonocytesRats

Identifiers

PMID27241794
PMCPMC5133203
OpenAlexW2411166269

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.